OOIR: Observatory of International Research

Papers

(The H4-Index of Neuropharmacology is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease	512
Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration	187
Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism	99
Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator	83
Sex differences in vulnerability to addiction	69
Better living through understanding the insula: Why subregions can make all the difference	69
Acetylcholinesterase inhibitors (nerve agents) as weapons of mass destruction: History, mechanisms of action, and medical countermeasures	69
Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson's disease model	64
The cannabinoid system and microglia in health and disease	60
NMDA receptors and synaptic plasticity in the anterior cingulate cortex	51
Impulsivity traits and neurocognitive mechanisms conferring vulnerability to substance use disorders	50
Inflammation at the crossroads of COVID-19, cognitive deficits and depression	49
The tripartite glutamatergic synapse	49
Arketamine, a new rapid-acting antidepressant: A historical review and future directions	49
AMPA receptor trafficking and LTP: Carboxy-termini, amino-termini and TARPs	48
Evolution of glutamatergic signaling and synapses	47
Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research	47
Organ and brain crosstalk: The liver-brain axis in gastrointestinal, liver, and pancreatic diseases	47
Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA	46
Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics	45
Ketamine and its metabolites: Potential as novel treatments for depression	44
Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways	44
Lithium alleviates blood-brain barrier breakdown after cerebral ischemia and reperfusion by upregulating endothelial Wnt/β-catenin signaling in mice	43
Loss of vagal integrity disrupts immune components of the microbiota-gut-brain axis and inhibits the effect of Lactobacillus rhamnosus on behavior and the corticosterone stress response	43
New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin	42

CNS pharmacology of NKCC1 inhibitors	42
Endocannabinoids, cannabinoids and the regulation of anxiety	42
Sex differences in pain along the neuraxis	42
How does the skeletal muscle communicate with the brain in health and disease?	40
Contrasting sex-dependent adaptations to synaptic physiology and membrane properties of prefrontal cortex interneuron subtypes in a mouse model of binge drinking	40
Neurobiological mechanisms of early life adversity, blunted stress reactivity and risk for addiction	40
Clinical and therapeutic significance of genetic variation in the GRIN gene family encoding NMDARs	39
Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1−42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease	39
Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson's disease	39
Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders	39
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression	39
Long-term effects of maternal cannabis vapor exposure on emotional reactivity, social behavior, and behavioral flexibility in offspring	39
TMS-EEG: An emerging tool to study the neurophysiologic biomarkers of psychiatric disorders	38
Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation	38
Promising vulnerability markers of substance use and misuse: A review of human neurobehavioral studies	38